Health Care Stock Winners and Losers: Eli Lilly

Eli Lilly launches its blood-thinner Efient in the U.K., and Procter & Gamble cuts jobs in Puerto Rico.
Author:
Publish date:

Updated from 2:49 p.m. EDT April 8

Widely held health care-related stocks were mostly up Wednesday amid a rally in the broader market.

Eli Lilly

(LLY) - Get Report

shares rose 1.2% to $32.34 Wednesday afternoon after the company, along with

Daiichi Sankyo

, launched blood-thinner Efient in the U.K. Efient, or prasugrel, was

approved in February

by European officials to help prevent blood clots in heart patients with stents. It will compete with Plavix, sold by

Bristol-Myers Squibb

(BMY) - Get Report

and

Sanofi-Aventis

(SNY) - Get Report

. Bristol shares rose 1.6% to $20.41. Sanofi-Aventis shares rose 0.5% to $27.71.

Also on the plus side was

Merck

(MRK) - Get Report

, shares of which rose 1.4% to $26.76.

Among the day's losers:

GlaxoSmithKline

(GSK) - Get Report

shares fell 0.3% to $30.06.

Pfizer

(PFE) - Get Report

shares fell 0.4% to $13.48 in choppy trading.

Procter & Gamble

(PG) - Get Report

shares fell 0.7% to $48.47 after the company said it was cutting about 90 jobs at a plant in Puerto Rico that makes Olay skin care products and Vicks cold medicine.